Hollsteen
← MACOM

D&A

Flow – sum over the period · $M

QuartersFiscal years

$MD&A · Q1 FY2016: $16.0M · 10-Q 0001193125-16-439832 filed Jan 27, 2016D&A · Q2 FY2016: $5.0M · 10-Q 0001193125-16-559543 filed Apr 27, 2016D&A · Q3 FY2016: $6.0M · 10-Q 0001493594-16-000007 filed Jul 27, 2016D&A · Q4 FY2016: $18.0M · derived · 10-K 0001493594-17-000055 filed Nov 15, 2017D&A · Q1 FY2017: $18.0M · 10-Q 0001493594-17-000012 filed Feb 1, 2017D&A · Q2 FY2017: $7.0M · 10-Q 0001493594-17-000037 filed Apr 26, 2017D&A · Q3 FY2017: $6.0M · 10-Q 0001493594-17-000046 filed Aug 2, 2017D&A · Q4 FY2017: $27.0M · derived · 10-K 0001493594-18-000034 filed Nov 16, 2018D&A · Q1 FY2018: $27.0M · 10-Q 0001493594-18-000008 filed Feb 7, 2018D&A · Q2 FY2018: $8.0M · 10-Q 0001493594-18-000019 filed May 3, 2018D&A · Q3 FY2018: $8.0M · 10-Q 0001493594-18-000026 filed Aug 1, 2018D&A · Q4 FY2018: $29.0M · derived · 10-K 0001493594-19-000064 filed Nov 26, 2019D&A · Q1 FY2019: $28.0M · 10-Q 0001493594-19-000008 filed Feb 6, 2019D&A · Q2 FY2019: $8.0M · 10-Q 0001493594-19-000022 filed May 8, 2019D&A · Q3 FY2019: $7.0M · 10-Q 0001493594-19-000051 filed Aug 6, 2019D&A · Q4 FY2019: $20.0M · derived · 10-K 0001493594-20-000063 filed Nov 18, 2020D&A · Q1 FY2020: $21.0M · 10-Q 0001493594-20-000017 filed Jan 29, 2020D&A · Q2 FY2020: $7.0M · 10-Q 0001493594-20-000037 filed Apr 30, 2020D&A · Q3 FY2020: $7.0M · 10-Q 0001493594-20-000051 filed Jul 30, 2020D&A · Q4 FY2020: $19.0M · derived · 10-K 0001493594-21-000079 filed Nov 15, 2021D&A · Q1 FY2021: $18.0M · 10-Q 0001493594-21-000014 filed Jan 28, 2021D&A · Q2 FY2021: $6.0M · 10-Q 0001493594-21-000056 filed Apr 29, 2021D&A · Q3 FY2021: $6.0M · 10-Q 0001493594-21-000072 filed Jul 29, 2021D&A · Q4 FY2021: $17.0M · derived · 10-K 0001493594-22-000047 filed Nov 14, 2022D&A · Q1 FY2022: $15.0M · 10-Q 0001493594-22-000011 filed Jan 27, 2022D&A · Q2 FY2022: $6.0M · 10-Q 0001493594-22-000025 filed Apr 28, 2022D&A · Q3 FY2022: $6.0M · 10-Q 0001493594-22-000037 filed Jul 28, 2022D&A · Q4 FY2022: $14.0M · derived · 10-K 0001493594-23-000081 filed Nov 13, 2023D&A · Q1 FY2023: $13.0M · 10-Q 0001493594-23-000035 filed Feb 2, 2023D&A · Q2 FY2023: $6.0M · 10-Q 0001493594-23-000046 filed May 4, 2023D&A · Q3 FY2023: $6.0M · 10-Q 0001493594-23-000057 filed Aug 3, 2023D&A · Q4 FY2023: $14.0M · derived · 10-K 0001493594-24-000060 filed Nov 12, 2024D&A · Q1 FY2024: $14.0M · 10-Q 0001493594-24-000028 filed Feb 1, 2024D&A · Q2 FY2024: $8.0M · 10-Q 0001493594-24-000040 filed May 2, 2024D&A · Q3 FY2024: $8.0M · 10-Q 0001493594-24-000052 filed Aug 1, 2024D&A · Q4 FY2024: $18.0M · derived · 10-K 0001493594-25-000054 filed Nov 14, 2025D&A · Q1 FY2025: $16.0M · 10-Q 0001493594-25-000020 filed Feb 6, 2025D&A · Q2 FY2025: $7.0M · 10-Q 0001493594-25-000029 filed May 8, 2025D&A · Q3 FY2025: $8.0M · 10-Q 0001493594-25-000038 filed Aug 7, 2025D&A · Q4 FY2025: $18.0M · derived · 10-K 0001493594-25-000054 filed Nov 14, 2025D&A · Q1 FY2026: $15.0M · 10-Q 0001493594-26-000019 filed Feb 5, 2026D&A · Q2 FY2026: $10.0M · 10-Q 0001493594-26-000028 filed May 7, 2026D&A · Q3 FY2026: $10.0M · 10-Q 0001493594-26-000038 filed Aug 6, 20265.29.515.928.7aQ1 FY2016Q3 FY2026
$MD&A · Q1 FY2016: $16.0M · 10-Q 0001193125-16-439832 filed Jan 27, 2016D&A · Q2 FY2016: $5.0M · 10-Q 0001193125-16-559543 filed Apr 27, 2016D&A · Q3 FY2016: $6.0M · 10-Q 0001493594-16-000007 filed Jul 27, 2016D&A · Q4 FY2016: $18.0M · derived · 10-K 0001493594-17-000055 filed Nov 15, 2017D&A · Q1 FY2017: $18.0M · 10-Q 0001493594-17-000012 filed Feb 1, 2017D&A · Q2 FY2017: $7.0M · 10-Q 0001493594-17-000037 filed Apr 26, 2017D&A · Q3 FY2017: $6.0M · 10-Q 0001493594-17-000046 filed Aug 2, 2017D&A · Q4 FY2017: $27.0M · derived · 10-K 0001493594-18-000034 filed Nov 16, 20185.227.2a15.9Q1 FY2016Q4 FY2017
Q2 FY2016
5.2$M
All values (43)
PeriodValue ($M)Status
Q3 FY20269.5reported
Q2 FY20269.5reported
Q1 FY202615.4reported
Q4 FY202517.6derived
Q3 FY20257.5reported
Q2 FY20257.4reported
Q1 FY202516.0reported
Q4 FY202417.8derived
Q3 FY20247.9reported
Q2 FY20247.8reported
Q1 FY202414.3reported
Q4 FY202313.7derived
Q3 FY20235.9reported
Q2 FY20235.8reported
Q1 FY202312.9reported
Q4 FY202214.2derived
Q3 FY20225.9reported
Q2 FY20225.8reported
Q1 FY202215.2reported
Q4 FY202117.1derived
Q3 FY20215.8reported
Q2 FY20216.0reported
Q1 FY202118.2reported
Q4 FY202019.1derived
Q3 FY20207.1reported
Q2 FY20207.3reported
Q1 FY202020.5reported
Q4 FY201919.8derived
Q3 FY20197.3reported
Q2 FY20197.6reported
Q1 FY201928.2reported
Q4 FY201828.7derived
Q3 FY20187.7reported
Q2 FY20187.6reported
Q1 FY201826.9reported
Q4 FY201727.2derived
Q3 FY20176.5reported
Q2 FY20177.2reported
Q1 FY201718.5reported
Q4 FY201618.0derived
Q3 FY20165.7reported
Q2 FY20165.2reported
Q1 FY201615.9reported

CSV with all sources · Technical ID: dna

More metrics for MACOM

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$5.0M
Period
Q2 FY2016, ended Apr 1, 2016 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Apr 27, 2016 · 0001193125-16-559543
Location
us-gaap:DepreciationAndAmortization
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Basis
Prüfhinweis: sum of the Quarters (45M) weicht vom GJ-Wert (71M) ab; Ursache aus den SEC-Daten not eindeutig (e.g. andere Abgrenzung im 10-K als in den 10-Qs). Werte unverändert wie reported.

Versions

v1$5.0MApr 27, 201610-Q 0001193125-16-559543reported · confidence 1. · current